Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search

We found 1,386 results for "Business Crimes Bulletin"...

In the Courts
April 27, 2011
Analysis of a recent ruling by the Fifth Circuit.
Business Crimes Hotline
April 27, 2011
Recent important rulings.
Major Embezzlements
April 27, 2011
Embezzlements are rarely large enough to cause major concern to in-house counsel, directors, officers and other members of management. But under at least four scenarios, embezzlements can threaten an entity's ability to execute its overall strategy.
Insuring Against Cyber Crime
March 28, 2011
Law firms are ranked ninth in terms of organizations with the highest risk of cyber exposure.
In the Courts
March 27, 2011
In-depth analysis of important key cases.
Business Crimes Hotline
March 27, 2011
Recent national rulings of interest.
IRS Offers Second Chance to Taxpayers with Undeclared Foreign Holdings
March 27, 2011
Doing nothing is increasingly not a viable option for anyone who wants to be able to use and enjoy their undisclosed foreign accounts or assets.
Civil FBAR Penalties
March 27, 2011
A recent decision provides a glimmer of hope that in both criminal and civil cases involving foreign accounts, lower FBAR penalties are possible and worth pursuing.
The Pitfalls and Prospects of Bank Prosecutions
March 27, 2011
A dramatic increase in criminal prosecutions of financial institution directors and officers is not likely. Here's why.
Business Crimes Hotline
February 27, 2011
Nationwide rulings that affect your practice.

MOST POPULAR STORIES

  • Surveys in Patent Infringement Litigation: The Next Frontier
    Most experienced intellectual property attorneys understand the significant role surveys play in trademark infringement and other Lanham Act cases, but relatively few are likely to have considered the use of such research in patent infringement matters. That could soon change in light of the recent admission of a survey into evidence in <i>Applera Corporation, et al. v. MJ Research, Inc., et al.</i>, No. 3:98cv1201 (D. Conn. Aug. 26, 2005). The survey evidence, which showed that 96% of the defendant's customers used its products to perform a patented process, was admitted as evidence in support of a claim of inducement to infringe. The court admitted the survey into evidence over various objections by the defendant, who had argued that the inducement claim could not be proven without the survey.
    Read More ›
  • In the Spotlight
    On May 9, 2003, the U.S. Attorney's Office for the District of Massachusetts announced that Bayer Corporation, the pharmaceutical manufacturer, had been sentenced and ordered to pay a criminal fine of $5,590,800 stemming from its earlier plea of guilty to violating the Federal Prescription Drug Marketing Act by failing to list with the FDA its drug product, Cipro, that was privately labeled for an HMO. Such listing is required under the federal Food, Drug &amp; Cosmetic Act. The Federal Prescription Drug Marketing Act, Pub. L. 100-293, enacted on April 22, 1988, as modified on August 26, 1992 by the Prescription Drug Amendments (PDA) Pub. L. 102-353, 106 Stat. 941, amended sections 301, 303, 503, and 801 of the Federal Food, Drug, and Cosmetic Act, codified at 21 U.S.C. '' 331, 333, 353, 381, to establish requirements for distributing prescription drug samples.
    Read More ›